Financial statements Dermafillers
Balance sheet data of DERMAFILLERS
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 430 143,78 | 777 474,14 | 945 200,50 | 1 285 846,61 | 1 070 779,36 | 929 863,32 |
A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 14 809,26 |
B. Current assets | 430 143,78 | 777 474,14 | 945 200,50 | 1 285 846,61 | 1 070 779,36 | 915 054,06 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
Total liabilities | 430 143,78 | 777 474,14 | 945 200,50 | 1 285 846,61 | 1 070 779,36 | 929 863,32 |
A. Equity | 140 704,32 | 125 600,37 | 70 718,26 | 950,53 | -48 871,55 | -256 883,91 |
B. Liabilities and provisions for liabilities | 289 439,46 | 651 873,77 | 874 482,24 | 1 284 896,08 | 1 119 650,91 | 1 186 747,23 |
I. Long-term liabilities | - | - | - | - | - | - |
II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.